These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30801864)
1. Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma. Kawamura A; Kawamura T; Riddell M; Hikita T; Yanagi T; Umemura H; Nakayama M Cancer Sci; 2019 May; 110(5):1780-1789. PubMed ID: 30801864 [TBL] [Abstract][Full Text] [Related]
2. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Riddell M; Nakayama A; Hikita T; Mirzapourshafiyi F; Kawamura T; Pasha A; Li M; Masuzawa M; Looso M; Steinbacher T; Ebnet K; Potente M; Hirose T; Ohno S; Fleming I; Gattenlöhner S; Aung PP; Phung T; Yamasaki O; Yanagi T; Umemura H; Nakayama M Nat Commun; 2018 Dec; 9(1):5357. PubMed ID: 30559384 [TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance. Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion. Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033 [TBL] [Abstract][Full Text] [Related]
5. Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups. Tomassen T; Weidema ME; Hillebrandt-Roeffen MHS; van der Horst C; ; Desar IME; Flucke UE; Versleijen-Jonkers YMH Immunol Res; 2022 Apr; 70(2):256-268. PubMed ID: 35043369 [TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer. Zhou C; Che G; Zheng X; Qiu J; Xie Z; Cong Y; Pei X; Zhang H; Sun H; Ma H J Cancer Res Clin Oncol; 2019 Nov; 145(11):2663-2674. PubMed ID: 31541338 [TBL] [Abstract][Full Text] [Related]
7. Atypical Protein Kinase C λ/ι Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma. Baba J; Kioi M; Akimoto K; Nagashima Y; Taguri M; Inayama Y; Aoki I; Ohno S; Mitsudo K; Tohnai I Anticancer Res; 2018 Nov; 38(11):6291-6297. PubMed ID: 30396949 [TBL] [Abstract][Full Text] [Related]
8. MYC regulates the antitumor immune response through CD47 and PD-L1. Casey SC; Tong L; Li Y; Do R; Walz S; Fitzgerald KN; Gouw AM; Baylot V; Gütgemann I; Eilers M; Felsher DW Science; 2016 Apr; 352(6282):227-31. PubMed ID: 26966191 [TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis. Lobrano R; Paliogiannis P; Zinellu A; Palmieri G; Persico I; Mangoni AA; Cossu A Curr Oncol; 2023 May; 30(5):5135-5144. PubMed ID: 37232846 [TBL] [Abstract][Full Text] [Related]
10. Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma. Gambichler T; Koim S; Wrobel M; Käfferlein HU; Brüning T; Stockfleth E; Becker JC; Lang K J Immunother; 2020 Jun; 43(5):169-174. PubMed ID: 32224717 [TBL] [Abstract][Full Text] [Related]
11. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1. Fan P; Ma J; Jin X Biochem Biophys Res Commun; 2018 Nov; 505(3):830-836. PubMed ID: 30301530 [TBL] [Abstract][Full Text] [Related]
12. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036 [TBL] [Abstract][Full Text] [Related]
13. MYC expression correlates with PD-L1 expression in non-small cell lung cancer. Kim EY; Kim A; Kim SK; Chang YS Lung Cancer; 2017 Aug; 110():63-67. PubMed ID: 28676221 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression. Pyo JS; Ko SH; Ko YS; Kim NY Pathol Res Pract; 2020 Feb; 216(2):152764. PubMed ID: 31836325 [TBL] [Abstract][Full Text] [Related]
15. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230 [TBL] [Abstract][Full Text] [Related]
17. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer. Wang J; Jia Y; Zhao S; Zhang X; Wang X; Han X; Wang Y; Ma M; Shi J; Liu L Oncogene; 2017 Nov; 36(45):6235-6243. PubMed ID: 28714960 [TBL] [Abstract][Full Text] [Related]
18. EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells. Wang Y; Hu J; Wang Y; Ye W; Zhang X; Ju H; Xu D; Liu L; Ye D; Zhang L; Zhu D; Deng J; Zhang Z; Liu S Cell Cycle; 2018; 17(12):1457-1470. PubMed ID: 29954240 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells. Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110 [TBL] [Abstract][Full Text] [Related]
20. High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence. Takagawa R; Akimoto K; Ichikawa Y; Akiyama H; Kojima Y; Ishiguro H; Inayama Y; Aoki I; Kunisaki C; Endo I; Nagashima Y; Ohno S Ann Surg Oncol; 2010 Jan; 17(1):81-8. PubMed ID: 19774416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]